Site Members can sign up for company wide alerts
Investigation Overview
May 27, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of XenoPort, Inc. (NASDAQ:XNPT), was announced concerning whether the takeover of XenoPort, Inc. by Arbor Pharmaceuticals, LLC for $7.03 per share is unfair to NASDAQ:XNPT stockholders. The investigation by a law firm concerns whether certain officers and directors of XenoPort, ...
You must register (for free) or login to view the entire investigation.